WINDLAS BIOTECH Financial Statement Analysis
|
||
|
The Revenues of WINDLAS BIOTECH have increased by 22.97% YoY .
The Earnings Per Share (EPS) of WINDLAS BIOTECH has increased by 37.36 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
WINDLAS BIOTECH Last 5 Annual Financial Results
[BOM: 543329|NSE : WINDLAS]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹631 Cr | ₹513 Cr | ₹466 Cr | ₹428 Cr | ₹329 Cr |
| Expenses | ₹553 Cr | ₹453 Cr | ₹414 Cr | ₹373 Cr | ₹287 Cr |
| Operating Profit (Excl OI) | ₹78 Cr | ₹60 Cr | ₹52 Cr | ₹55 Cr | ₹41 Cr |
| Other Income | ₹13 Cr | ₹9.97 Cr | ₹6.71 Cr | ₹3.09 Cr | ₹2.49 Cr |
| Interest | ₹1.11 Cr | ₹0.79 Cr | ₹1.42 Cr | ₹1.29 Cr | ₹2.53 Cr |
| Depreciation | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹13 Cr | ₹9.29 Cr |
| Profit Before Tax | ₹77 Cr | ₹57 Cr | ₹46 Cr | ₹22 Cr | ₹25 Cr |
| Profit After Tax | ₹58 Cr | ₹43 Cr | ₹38 Cr | ₹16 Cr | ₹16 Cr |
| Consolidated Net Profit | ₹58 Cr | ₹43 Cr | ₹38 Cr | ₹16 Cr | ₹16 Cr |
| Earnings Per Share (Rs) | ₹27.98 | ₹20.37 | ₹17.48 | ₹24.70 | ₹25.29 |
| PAT Margin (%) | 9.22 | 8.31 | 8.17 | 3.64 | 4.93 |
| ROE(%) | 13.78 | 10.76 | 12.87 | 7.62 | 8.04 |
| ROCE(%) | 18.34 | 14.39 | 14.88 | 9.85 | 11.81 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.02 | 0.16 | 0.13 |
Key Financials |
||
| Market Cap | : | ₹ 2,112.2 Cr |
| Revenue (TTM) | : | ₹ 695.7 Cr |
| Net Profit(TTM) | : | ₹ 61.2 Cr |
| EPS (TTM) | : | ₹ 29.2 |
| P/E (TTM) | : | 34.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| WINDLAS BIOTECH | 3.9% | -2.2% | 105.5% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.3% | -4.7% | 22.8% |
| CIPLA | -0.7% | -3.3% | 2.1% |
| DR REDDYS LABORATORIES | 2.1% | -9.7% | -0.3% |
| ZYDUS LIFESCIENCES | 2.1% | -2.8% | 26.4% |
| DIVIS LABORATORIES | 6.3% | 3.3% | 59.2% |
| MANKIND PHARMA | 2.5% | -12.6% | 26.8% |
| TORRENT PHARMACEUTICALS | -7.5% | -8.8% | 25.5% |
| LUPIN | 2.2% | -10.5% | 35.3% |
WINDLAS BIOTECH Revenues
[BOM: 543329|NSE : WINDLAS]
| Y-o-Y | 22.97 % |
| 5 Yr CAGR | 17.69 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹631 Cr | 22.97 | |
| Mar2023 | ₹513 Cr | 10.12 | |
| Mar2022 | ₹466 Cr | 8.96 | |
| Mar2021 | ₹428 Cr | 30.03 | |
| Mar2020 | ₹329 Cr | - | |
WINDLAS BIOTECH Operating Profit
[BOM: 543329|NSE : WINDLAS]
| Y-o-Y | 29.80 % |
| 5 Yr CAGR | 17.18 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹78 Cr | 29.80 | |
| Mar2023 | ₹60 Cr | 14.88 | |
| Mar2022 | ₹52 Cr | -4.15 | |
| Mar2021 | ₹55 Cr | 31.90 | |
| Mar2020 | ₹41 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 5.54 % |
| 5 Yr CAGR | -0.44 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 12.39% | 5.54 | |
| Mar2023 | 11.74% | 4.36 | |
| Mar2022 | 11.25% | -12.04 | |
| Mar2021 | 12.79% | 1.43 | |
| Mar2020 | 12.61% | - | |
WINDLAS BIOTECH Profit After Tax
[BOM: 543329|NSE : WINDLAS]
| Y-o-Y | 36.51 % |
| 5 Yr CAGR | 37.64 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹58 Cr | 36.51 | |
| Mar2023 | ₹43 Cr | 11.91 | |
| Mar2022 | ₹38 Cr | 140.58 | |
| Mar2021 | ₹16 Cr | -2.35 | |
| Mar2020 | ₹16 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 10.95 % |
| 5 Yr CAGR | 16.94 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 9.22 % | 10.95 | |
| Mar2023 | 8.31 % | 1.71 | |
| Mar2022 | 8.17 % | 124.45 | |
| Mar2021 | 3.64 % | -26.17 | |
| Mar2020 | 4.93 % | - | |
WINDLAS BIOTECH Earnings Per Share (EPS)
[BOM: 543329|NSE : WINDLAS]
| Y-o-Y | 37.36 % |
| 5 Yr CAGR | 2.56 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹28 | 37.36 | |
| Mar2023 | ₹20 | 16.53 | |
| Mar2022 | ₹17 | -29.23 | |
| Mar2021 | ₹25 | -2.33 | |
| Mar2020 | ₹25 | - | |
WINDLAS BIOTECH Return on Capital Employed (ROCE)
[BOM: 543329|NSE : WINDLAS]
| Y-o-Y | 27.45 % |
| 5 Yr CAGR | 11.63 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 18.34% | 27.45 | |
| Mar2023 | 14.39% | -3.29 | |
| Mar2022 | 14.88% | 51.07 | |
| Mar2021 | 9.85% | -16.60 | |
| Mar2020 | 11.81% | - | |
WINDLAS BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹1,005.8 |
| Current MarketCap | : | ₹ 2,112.2 Cr |
| Updated EOD on | : | Feb 04,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 3.9% |
-2.2% |
105.5% |
| SENSEX | 2.7% |
0.8% |
9.7% |
WINDLAS BIOTECH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.4% | -5.3% | 26.3% |
| S&P BSE MIDSMALLCAP | 3.3% | -11% | 8.6% |
| S&P BSE SMALL CAP | 1.5% | -8.4% | 9.2% |
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
No NSE index found
You may also like the below Video Courses
FAQ about WINDLAS BIOTECH Financials
How the annual revenues of WINDLAS BIOTECH have changed ?
The Revenues of WINDLAS BIOTECH have increased by 22.97% YoY .
How the Earnings per Share (EPS) of WINDLAS BIOTECH have changed?
The Earnings Per Share (EPS) of WINDLAS BIOTECH has increased by 37.36 % YoY .
Check out Intrinsic Value of Peers of WINDLAS BIOTECH
Compare Stock Analytics of Peers of WINDLAS BIOTECH
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
